Nightingale's investor pages

Investors
Home
Nightingale as an investment
Key strengths
Operational environment
Strategy
Dividends policy
Financial information
Key figures
Share and shareholders
Share information
Share monitor
Shareholders
Authorisations
Governance
Governance principles
General Meeting
Board of Directors
Management Team
Remuneration
Risk management
Insider management
Managers' transactions
Auditor
Certified Adviser
Articles of Association
Code of Conduct
Investor relations
Investor calendar
Investor contacts
Disclosure policy
Releases
Company releases
Press releases
Managers' transactions
IPO
IPO 2021
Investors

Nightingale's investor pages

Share graph

Releases

9/4/2021 Nightingale Health Plc’s subsidiary received clinical laboratory certification in Japan

7/4/2021 Nightingale Health Plc – Managers' transactions – Timo Soininen

31/3/2021 The cancellation of Nightingale Health Plc’s treasury shares entered in the Trade Register

30/3/2021 Nightingale Health Plc – Managers' transactions – Timo Soininen

25/3/2021 Nightingale Health Plc’s ten largest shareholders after the completion of the initial public offering

All releases


Contact us

ir@nightingalehealth.com

For individuals
Blood test and app
Blog
FAQ
Buy
Sign in
For business
Nightingale for business
Health initiatives
For investors
Investor pages
Nightingale as an investment
Financial information
Share and shareholders
Governance
Investor relations
Releases
IPO
Suomeksi
For research
Blood Biomarker Analysis
Biomarkers
Publications
About us
Company
Technology
News
Careers
Contact
Get our newsletter
Interested in getting the latest news about Nightingale? Subscribe to our newsletter.
Nightingale Health Oyj
Mannerheimintie 164a, 00300 Helsinki, Finland
Contact →
© 2020 Nightingale HealthTerms and policies